Literature DB >> 23089279

Prostaglandin F2α regulation of mRNA for activating protein 1 transcriptional factors in porcine corpora lutea (CL): lack of induction of JUN and JUND in CL without luteolytic capacity.

F J Diaz1, W Luo, M C Wiltbank.   

Abstract

Porcine corpora lutea (CL) develop sensitivity to regression by prostaglandin F2α (PGF2α), termed luteolytic capacity, about 13 d after estrus. We postulated that PGF2α regulation of activating protein 1 (AP-1) transcriptional factor expression underlies acquisition of luteolytic capacity. CL were collected from gilts on day 9 (estrous cycle) or day 17 (pseudopregnancy) before or after PGF2α treatment with mRNA measured for FOS, FOSB, FOSL1, FOSL2, JUN, JUNB, and JUND and the AP-1 target genes CCL2 and SERPINE1. At 0.5 h after PGF2α, both day-9 and day-17 CL had increased (P < 0.01) mRNA for FOS (2,225% and 1,817%), JUNB (237% and 358%), and FOSB (1,060% and 925%). Intriguingly, at 0.5 h after PGF2α there was increased (P < 0.01) mRNA encoding JUN (1,099%) and JUND (300%) in day-17 but not day-9 CL. At 10 h after PGF2α there was elevated FOSB mRNA in day-17 (771%) but not day-9 CL and no PGF2α-induced change in FOS, JUN, JUND, and JUNB mRNA in day-9 or day-17 CL. Treatment with PGF2α increased mRNA for AP-1-responsive genes, CCL2 at 0.5 h (202%) and CCL2 and SERPINE1 at 10 h (719% and 1,515%), only in day-17 CL. Thus, many of the fos family of transcription factors are dramatically induced by PGF2α in CL with or without luteolytic capacity. However, PGF only induced JUN and JUND expression in CL with luteolytic capacity, a finding that may be key for understanding the acquisition of luteolytic capacity, given that JUN is the only AP-1 family member with strong N-terminal trans-activation activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089279      PMCID: PMC5939928          DOI: 10.1016/j.domaniend.2012.09.005

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  45 in total

1.  Hormonal regulation of monocyte chemoattractant protein-1 messenger ribonucleic acid expression in corpora lutea.

Authors:  S J Tsai; J L Juengel; M C Wiltbank
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  Induction of c-fos and c-jun messenger ribonucleic acid expression by prostaglandin F2alpha is mediated by a protein kinase C-dependent extracellular signal-regulated kinase mitogen-activated protein kinase pathway in bovine luteal cells.

Authors:  D Chen; H W Fong; J S Davis
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

3.  The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription.

Authors:  A Schönthal; M Büscher; P Angel; H J Rahmsdorf; H Ponta; K Hattori; R Chiu; M Karin; P Herrlich
Journal:  Oncogene       Date:  1989-05       Impact factor: 9.867

4.  Distinct regulation by steroids of messenger RNAs for FSHR and CYP19A1 in bovine granulosa cells.

Authors:  Wenxiang Luo; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2006-04-26       Impact factor: 4.285

5.  Administration of prostaglandin f(2 alpha) during the early bovine luteal phase does not alter the expression of ET-1 and of its type A receptor: a possible cause for corpus luteum refractoriness.

Authors:  N Levy; S Kobayashi; Z Roth; D Wolfenson; A Miyamoto; R Meidan
Journal:  Biol Reprod       Date:  2000-08       Impact factor: 4.285

6.  Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition.

Authors:  P Finzer; U Soto; H Delius; A Patzelt; J F Coy; A Poustka; H zur Hausen; F Rösl
Journal:  Oncogene       Date:  2000-07-06       Impact factor: 9.867

7.  A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.

Authors:  S T Eichhorst; M Müller; M Li-Weber; H Schulze-Bergkamen; P Angel; P H Krammer
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

8.  Expression and distribution of AP-1 transcription factors in the porcine ovary.

Authors:  Raluca Rusovici; Holly A LaVoie
Journal:  Biol Reprod       Date:  2003-02-19       Impact factor: 4.285

Review 9.  Luteal function: the estrous cycle and early pregnancy.

Authors:  G D Niswender; J L Juengel; W J McGuire; C J Belfiore; M C Wiltbank
Journal:  Biol Reprod       Date:  1994-02       Impact factor: 4.285

10.  The AP-1 transcription factor c-Jun is required for efficient axonal regeneration.

Authors:  Gennadij Raivich; Marion Bohatschek; Clive Da Costa; Osuke Iwata; Matthias Galiano; Maria Hristova; Abdolrahman S Nateri; Milan Makwana; Lluís Riera-Sans; David P Wolfer; Hans-Peter Lipp; Adriano Aguzzi; Erwin F Wagner; Axel Behrens
Journal:  Neuron       Date:  2004-07-08       Impact factor: 17.173

View more
  4 in total

1.  Female mice with loss-of-function ITCH display an altered reproductive phenotype.

Authors:  Angela R Stermer; Jessica L Myers; Caitlin J Murphy; Kristin R Di Bona; Lydia Matesic; John H Richburg
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-28

2.  Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy.

Authors:  Chie Suzuki; Koji Yoshioka; Manabu Yamada; Toru Miyamoto; Noboru Manabe
Journal:  Vet Res Commun       Date:  2013-09-22       Impact factor: 2.459

3.  FOS, a Critical Downstream Mediator of PGR and EGF Signaling Necessary for Ovulatory Prostaglandins in the Human Ovary.

Authors:  Yohan Choi; Katherine L Rosewell; Mats Brännström; James W Akin; Thomas E Curry; Misung Jo
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

4.  Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation.

Authors:  Courtney Waite; Rachel Mejia; Mario Ascoli
Journal:  Biol Reprod       Date:  2016-02-03       Impact factor: 4.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.